DUBLIN, March 14, 2017 /PRNewswire/ -- See America,
Allergan's initiative to fight against preventable blindness in
the United States, today unveiled
a powerful video featuring award-winning actor and hip-hop artist
Common, that urges Americans to "stand in the way of darkness".
Experience the interactive Multimedia News Release here:
https://www.multivu.com/players/English/8057551-common-joins-allergan-see-america-against-preventable-blindness/
The video harnesses Common's striking spoken word ability,
calling on Americans to fight against vision loss and prioritize
their vision. Common highlights the 61 million Americans at-risk of
severe vision loss1, and challenges us all to imagine a
life without sight.
"I'm proud to join Allergan in the fight against preventable
blindness," said Common. "Sight is something that far too many of
us take for granted. I hope our message resonates with people
across the country, no matter what age or background."
Common's involvement echoes the mission of Allergan's
See America initiative by raising
awareness to make sure that each and every one of us makes the time
to prioritize our vision. Taking steps as simple as regular
comprehensive eye exams can help detect eye diseases like glaucoma,
diabetic retinopathy or age-related macular degeneration early,
before irreversible damage is done.2
On Common's partnership with See
America, "We are excited to have joined forces with Common
to raise awareness of the important issue of preventable blindness
in America. This video marks the first of many ways in which we aim
to educate and engage the public. Common shares our bold approach
to life, and we believe that this video will take us one step
closer to nationwide appreciation for the gift of sight," said Herm
Cukier, Allergan Senior Vice President of Eye Care.
To watch the video, and to learn more about See
America, visit www.SeeAmerica.vision.
ABOUT SEE AMERICA:
Allergan, a global leader in eye care for nearly 70 years, has
recently launched See America to
fight against preventable blindness and vision impairment in
America. See America has set out to
make vision health a priority across the U.S., increase awareness
of diseases that cause preventable blindness, and bring critical
access to vision care to those who need it most. To find out more
about See America, visit
www.SeeAmerica.vision
ABOUT ALLERGAN PLC.
Allergan plc (NYSE: AGN),
headquartered in Dublin, Ireland,
is a bold, global pharmaceutical company and a leader in a new
industry model – Growth Pharma. Allergan is focused on
developing, manufacturing and commercializing branded
pharmaceuticals, devices and biologic products for patients around
the world.
Allergan markets a portfolio of leading brands and best-in-class
products for the central nervous system, eye care, medical
aesthetics and dermatology, gastroenterology, women's health,
urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, the Company's
R&D model, which defines our approach to identifying and
developing game-changing ideas and innovation for better patient
care. This approach has led to Allergan building one of the
broadest development pipelines in the pharmaceutical industry with
70+ mid-to-late stage pipeline programs in development.
Our Company's success is powered by our more than 16,000 global
colleagues' commitment to being Bold for Life. Together, we
build bridges, power ideas, act fast and drive results for our
customers and patients around the world by always doing what is
right.
With commercial operations in approximately 100 countries,
Allergan is committed to working with physicians, healthcare
providers and patients to deliver innovative and meaningful
treatments that help people around the world live longer, healthier
lives every day.
For more information, visit Allergan's website at
www.Allergan.com
Allergan Forward-Looking Statement
Statements contained in this press release that refer to future
events or other non-historical facts are forward-looking statements
that reflect Allergan's current perspective of existing trends and
information as of the date of this release. Except as expressly
required by law, Allergan disclaims any intent or obligation to
update these forward-looking statements. Actual results may differ
materially from Allergan's current expectations depending upon a
number of factors affecting Allergan's business. These factors
include, among others, the difficulty of predicting the timing or
outcome of FDA approvals or actions, if any; the impact of
competitive products and pricing; market acceptance of and
continued demand for Allergan's products; difficulties or delays in
manufacturing; and other risks and uncertainties detailed in
Allergan's periodic public filings with the Securities and Exchange
Commission, including but not limited to Allergan's Annual Report
on Form 10-K for the year ended December 31,
2016. Except as expressly required by law, Allergan
disclaims any intent or obligation to update these forward-looking
statements.
1 CDC_Keep an Eye on Your Vision Health
2 CDC_Keep an Eye on Your Vision Health
CONTACTS:
Media:
Mark Marmur
mark.marmur@allergan.com
+1 (862) 261 7558
Suzanne Jacobson
suzanne.jacobson@allergan.com
+1 (201) 427 8879
Karina Calzadilla
investorrelations@allergan.com
+1 (862) 261 7328
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/award-winning-actor-and-hip-hop-artist-common-joins-allergans-see-americasm-initiative-to-further-the-fight-against-preventable-blindness-300423254.html
SOURCE Allergan